TY - JOUR T1 - Dr. Malaviya, <em>et al</em> reply JF - The Journal of Rheumatology JO - J Rheumatol SP - 1543 LP - 1543 DO - 10.3899/jrheum.100175 VL - 37 IS - 7 AU - ANAND N. MALAVIYA AU - SANJIV KAPOOR AU - SHRIRAM GARG AU - ROOPA RAWAT AU - SUBRAMANIAN SHANKAR AU - SAVITA NAGPAL AU - DINESH KHANNA Y1 - 2010/07/01 UR - http://www.jrheum.org/content/37/7/1543.1.abstract N2 - To the Editor:Kharbanda, et al report development of tuberculosis (TB) infection in 2 of their patients, 3 weeks and 3 months after the last dose of infliximab, despite following the LTBI screening strategy suggested in our publication1. One of their patients was in a pediatric age group. We had also reported post infliximab TB infection in one of our patients despite … Address correspondence to Dr. A.N. Malaviya; E-mail: anand_malaviya{at}yahoo.com ER -